OLYMVAX Competitors and Similar CompaniesClear all
OLYMVAX's competitors and similar companies include UCB and Cipla.
 OLYMVAX Chengdu Olymvax Biopharmaceuticals (成都欧林生物科技股份有限公司) is a biopharmaceutical company that produces and sells vaccines. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |
Founding Date | Founding Date 2009 | Founding Date 1928 | Founding Date 1935 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Chengdu, CN HQ Chengdu, CN Chongqing, CN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 470 | Employees 9,052 | Employees 27,764 |
Valuation ($) | Valuation ($) 592 m | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥694.1m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods ¥49.6m (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit ¥648.5m (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit ₹195b (FY, 2026) |
Net income | Net income ¥21.9m (FY, 2025) | Net income €1.6b (FY, 2025) | Net income ₹38.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company